➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Merck
Express Scripts
Medtronic
McKinsey

Last Updated: June 2, 2020

DrugPatentWatch Database Preview

Glenmark Generics Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GLENMARK GENERICS, and what generic and branded alternatives to GLENMARK GENERICS drugs are available?

GLENMARK GENERICS has sixty-eight approved drugs.

There are three tentative approvals on GLENMARK GENERICS drugs.

Summary for Glenmark Generics
US Patents:0
Tradenames:59
Ingredients:54
NDAs:68
Patent Litigation for Glenmark Generics: See patent lawsuits for Glenmark Generics

Drugs and US Patents for Glenmark Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 090365-002 Dec 17, 2010 AB RX No No   Start Trial   Start Trial
Glenmark Generics TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 079135-004 Aug 30, 2010 RX No No   Start Trial   Start Trial
Glenmark Generics VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 078906-001 Sep 17, 2009 AB RX No No   Start Trial   Start Trial
Glenmark Generics ZOLMITRIPTAN zolmitriptan TABLET;ORAL 201779-001 May 14, 2013 AB RX No No   Start Trial   Start Trial
Glenmark Generics ZONISAMIDE zonisamide CAPSULE;ORAL 077651-001 Jan 30, 2006 AB RX No No   Start Trial   Start Trial
Glenmark Generics ZONISAMIDE zonisamide CAPSULE;ORAL 077651-002 Jan 30, 2006 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for GLENMARK GENERICS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Moodys
McKesson
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.